The Interplay Between Molecular Architecture, Pharmacology, and Suspected Adverse Drug Reactions Associated with Non-Steroidal Androgen Antagonists in The United Kingdom

Simrit Dhillon, Albert A. Antolin, Alan M. Jones
doi: https://doi.org/10.1101/2024.07.09.24309949

Article Information

doi 
https://doi.org/10.1101/2024.07.09.24309949
History 
  • July 9, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Simrit Dhillon1,
  2. Albert A. Antolin2,3 and
  3. Alan M. Jones1,*
  1. 1School of Pharmacy, University of Birmingham, Edgbaston, B15 2TT, United Kingdom
  2. 2ProCURE, Catalan Institute of Oncology (ICO) & Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), Barcelona, Catalonia, Spain
  3. 3Center for Cancer Drug Discovery, Division of Cancer Therapeutics, The Institute of Cancer Research, London SM2 5NG, UK
  1. ↵*Corresponding author: a.m.jones.2{at}bham.ac.uk
Back to top
Posted July 09, 2024.
Download PDF
Data/Code
Email
The Interplay Between Molecular Architecture, Pharmacology, and Suspected Adverse Drug Reactions Associated with Non-Steroidal Androgen Antagonists in The United Kingdom
Simrit Dhillon, Albert A. Antolin, Alan M. Jones
medRxiv 2024.07.09.24309949; doi: https://doi.org/10.1101/2024.07.09.24309949
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area